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Abstract: Apoptosis plays an important role in intervertebral disc degeneration (IDD). Overwhelming evidence in-
dicates that RASSF7 is essential for cell growth and apoptosis. Recently, it has been noted that the JNK signaling 
can be negatively regulated by suppressing phosphorylated-MKK7 activation during pro-apoptosis. We aimed to 
investigate the RASSF7 expression level in human degenerative nucleus pulposus (NP) cells and non-degenerative 
NP cells and the link between RASSF7-JNK with NP cells apoptosis. We harvested NP tissues from 20 IDD patients 
as disease group and 8 cadaveric donors as normal controls. We detected RASSF7 expression by Real-time-PCR and 
western blotting. Consequently, we found that the expression of RASSF7 was higher in non-degenerative group than 
in degenerative group (P<0.05). Overexpression of RASSF7 in degenerative NP cells led to decreased apoptosis 
rate than that in scramble group (P<0.05). Collectively, our findings suggest that RASSF7 plays an important role in 
human IDD and RASSF7 might be potentially developed as a curative agent.
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Introduction
As the most disabling condition globally, low 
back pain (LBP) is one of the biggest problems 
for public health systems in the world [1]. 
However, many factors have been identified as 
possible causes of LBP [2-5], one of which is 
intervertebral disc degeneration (IDD) [6]. IDD 
occurs frequently in adults and is tightly linked 
with low back pain and sciatica [7-11], which 
are the most common diseases resulting in 
morbidity with overwhelming socioeconomic 
consequences [1, 12-14]. Hitherto, the underly-
ing machinery of IDD has been largely unknown. 
We have noted that Fas-mediated apoptosis in 
human IDD can be promoted by the down regu-
lation of miR-155 [15-17]. Furthermore, we 
have addressed the expression profiles of long 
noncoding RNAs and mRNAs of human IDD, in 
particular the mRNAs pertaining to apoptosis 
[18]. Amongst the deregulated apoptosis-perti-
nent mRNAs, RASSF7 (NM_001143993) do- 
wn-regulated up to 70 fold in IDD (P=0.0000141).
RASSF comprises a conserved motif named 
the RalGDS/AF6-type Ras association domain. 
RASSF7 is a newly defined RASSF member. 
Initially, RASSF7 was noted as HRAS cluster 1 
on human chromosome 11p15.
In the past decade, apoptosis in IDD has ever 
become a research focus [13, 19]. Accumulating 
evidence suggests that apoptosis plays an 
essential role in pathogenesis of IDD in terms 
of in vitro, in vivo, studies [15, 20-22]. As for the 
apoptosis pathways, c-Jun N-terminal kinase 
(JNK) enzymes are important modulators of 
apoptosis in stress-activated signaling [23-27].
It is well established that Ras-association do- 
main family proteins are involved in the regula-
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tion of JNK pathway [28]. The vertebrate RAS- 
SF consist of the classical RASSF members 
(RASSF1-6) and the newly defined N-termin- 
al (NT) RASSF members (RASSF7-10) [29]. As 
the most investigated N-terminal RASSF pro-
tein, RASSF7 negatively modulates pro-apop-
totic JNK signaling by suppressing phosphory-
lated-MKK7 activation [25].
However, there have been no studies reporting 
RASSF7 and its attendant roles in human IDD 
until now. Therefore, our research was aimed to 
investigate the role of RASSF7 in human NP 
cells and its putative roles in IDD.
via a nylon mesh with pore-size of 45-μm. Cells 
were cultured for three weeks in DMEM/F12-
based culture medium, consisting of 15% fetal 
bovine serum (FBS; Gibco-BRL) and 1% penicil-
lin/streptomycin (Invitrogen) in a 5% CO2 incu-
bator. The culture medium was renewed twice a 
week. NP cells with passage 1 or 2 were adapt-
ed for further studies.
RNA isolation and qRT-PCR
NP tissues were harvested from cadavers and 
IDD patients. We extracted total RNA by Trizol 
reagent (Invitrogen, Carlsbad, CA, USA). cDNA 
was acquired by using High-Capacity cDNA 
Table 1. Demographic data of cadaveric donors and 
patients
Nucleus pulposus tissues Age Gender Level Degree*
Normal control (cadaveric donors)
    1 44 M L4/5 I
    2 38 M L4/5 I
    3 37 F L4/5 I
    4 45 M L4/5 I
    5 47 M L4/5 I
    6 39 F L4/5 I
    7 45 M L4/5 I
    8 39 M L4/5 I
IDD Group (IDD patients)
    9 47 F L4/5 IV
    10 52 M L4/5 IV
    11 43 F L4/5 V
    12 36 F L4/5 IV
    13 42 M L4/5 V
    14 50 F L5/S1 IV
    15 45 F L5/S1 IV
    16 41 M L4/5 IV
    17 38 M L4/5 IV
    18 35 F L5/S1 V
    19 39 M L4/5 IV
    20 42 F L5/S1 IV
    21 52 M L4/5 IV
    22 42 M L4/5 IV
    23 46 M L4/5 IV
    24 38 F L4/5 IV
    25 49 F L4/5 IV
    26 36 M L5/S1 IV
    27 43 F L4/5 IV
    28 51 M L4/5 IV
*Pfirrmann’s grading system.
Materials and methods
Sample collection
The Ethics Review Board of Xijing hospi-
tal, Xi’an, P. R. China (No. 20090611-3, 
No. 20111103-7) approved the study. 
As well, we signed informed consents 
with each patient and cadaveric donors’ 
relatives. NP tissues from IDD patients 
were collected as degenerative group 
during discectomy [n=20; mean age: 
43.4, SD: ±5.4; (range 35-52)] and nor-
mal cadaveric donors as control group 
[n=8; mean age: 41.8, SD: ±3.6; (range 
37-47)] as we previously reported (Table 
1). All the samples from patients with 
IDD were strictly selected to eliminate 
sequestration type of disc herniation. 
IDD degrees were classified by 3 experi-
enced clinical observers who were blind-
ed to the groups by Pfirrmann’s MRI 
grading system [30]. We carefully dis-
sected all samples under magnification 
and thereafter managed them in terms 
of specific conditions.
NP cell cultures
Following cautiously washed, redundant 
tissues including annulus fibrosus from 
outside of NP and cartilaginous end-
plate were detached. The rest of NP tis-
sues underwent digestion for 40 min in 
PBS with 0.25% pronase at 37°C (Gibco-
BRL, Carlsbad, CA, USA). Subsequently, 
further digestion was performed in PBS 
with 0.025% collagenase type II (In- 
vitrogen) for 4 h. Following washed triple 
times with PBS, the digest was filtered 
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Archive Kit (ABI, Foster City, CA, USA). Prime- 
rs for human RASSF7 and human GAPDH we- 
re purchased from Invitrogen (Invitrogen, NY, 
USA). NanoDrop (NanoDrop, Wilmington, DE, 
USA) was used to detect the concentrations of 
RNA. The RASSF7 expression levels were nor-
malized to GAPDH mRNA controls. All RT reac-
tions, including GAPDH controls, were run in 
triplicate in a GeneAmp PCR 9700 Thermocycler 
(ABI). The relative amounts of RASSF7 mRNA 
were calculated using the comparative Ct 
(2-ΔΔCt) method. The primers used were as fol-
lows: RASSF7 forward: 5’-CAAAGGCCACGACT- 
GCCTGTT-3’, reverse: 5’-GGCACAGGCAACATGA- 
CAGAGA-3’; GAPDH forward: 5’-GCACCGTCAA- 
GGCTGAGAAC-3’, reverse: 5’-TGGTGAAGACGC- 
CAGTGGA-3’.
Western blotting analysis
RASSF7 expression was detected by western 
blotting analysis in IDD group and control group. 
Following solubilizing cells in 2X SDS buffer, 
electrophoresized using 10% gel, proteins were 
transferred to PVDF membrane. The mem-
branes were incubated for 1 h at room tem- 
perature with rabbit-anti-human antibody for 
RASSF7 (Abcam, USA). Mouse antibody to β- 
actin (Sigma, Saint Louis, USA) was used as 
control. IRDye 800 anti-rabbit or anti-mouse 
IgG antibody (LI-COR Biosciences, Nebraska, 
USA) was used to label antibodies. LI-COR Od- 
yssey Imaging System was used to analyze 
expression levels.
Up-regulation of RASSF7 with lentiviral vector
We purchased lentiviral vectors encoding RA- 
SSF7 with green fluorescent protein (GFP) la- 
beling Genechem (Genechem, Shanghai, P. R. 
China). We used a scrambled sequence as con-
trol. In vitro cultured NP cells were inoculated 
(Density: 1.5×105 cells/well) into a 24-well 
plate. The final volume of complete medium 
was 250 µL. The multiplicity of infection (MOI) 
for viral solutions was 10. Following incubation 
for 10 h and 96 h of recovery, culture flasks 
were investigated under fluorescent microsco-
py to confirm viral transfection.
Flow cytometry (FCM) analysis
FCM of NP cells 1 d following transfection was 
performed with APC Annexin V/7-AAD (BD 
Biosciences, San Diego, CA, USA) staining using 
standard protocol. Triple repeats were per-
formed for each experiment.
Statistical analysis
For comparison between parameters of 2 gr- 
oups, student’s t-test was used. A P value less 
than 0.05 was considered as statistically sig-
nificant. The SPSS 12.0 statistical package 
(SPSS, Chicago, IL, USA) was used for statisti-
cal analyses.
Results
Different levels of RASSF7 expression in hu-
man degenerative and normal NP cells
The mRNA expression level of RASSF7 in IDD 
was considerably lower than that of normal 
control (Figure 1A). Furthermore, the intensity 
of RASSF7 in IDD group was lower than that in 
control as a result of western blotting (Figure 
1B). Quantitatively, the average RASSF7 per-
centage in IDD was mean: 0.243, SD: 0.03; 
whereas the average RASSF7 ratio in control 
was mean: 0.64, SD: 0.07 (P<0.05). Taken to- 
gether, these results indicate the existence of 
Figure 1. RASSF7 expression in degenerative NP cells. A. qRT-PCR analysis of RASSF7 expression. B. Western blot-
ting detection of RASSF7 expression.
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RASSF7 in human NP. Moreover, RASSF7 was 
down-regulated in human degenerative NP at 
both the mRNA and the protein level.
Up-regulation of RASSF7 in degenerated NP 
cells can lead to decreased apoptosis
The lentiviral transfection with RASSF7 led to 
GFP expression at high level (Figure 2A). FCM 
resulted in the apoptosis of transfected NP 
cells (Figure 2B). The apoptotic rate in up-regu-
lated RASSF7 group was mean: 0.197, SD: 
0.038. Approximately mean 0.50, SD: 0.114 
apoptosis rate was detected in control group 
(Figure 2C). Our study found that up-regulated 
RASSF7 resulted in decreased apoptotic rate 
of degenerative NP cells (P<0.05).
Discussion
This study presents the first line of evidence 
unraveling the function of RASSF7 in hum- 
an IDD. We detected the expression level of 
RASSF7 in human NP tissues and clarified its 
attendant roles in IDD for the first time. 
Importantly, in vitro modulation of RASSF7 
expression in human NP cells can influence 
apoptosis, which might provide novel insights 
on the etiology of human IDD in terms of apop-
tosis machinery. IDD is a complicated patho-
logical process, including various degenerative 
events such as cell death, miRNAs, gene poly-
morphisms and unbalanced immune privilege.
There are a number of lines of evidence indicat-
ing that apoptosis plays an essential role in 
pathogenesis of IDD [13, 19, 20]. Recently, 
researchers found that JNK enzymes, as the 
modulators of apoptosis, can be regulated by 
RASSF7 repressing the activity of phospho- 
rylated-MKK7 to affect cell apoptosis [25]. 
RASSF7, previously known asHRC1 (HRAS1 
cluster 1) and C11orf13, is a component of the 
N-terminal RASSF family [31]. Previous studies 
have shown that RASSF7 has putative roles in 
the regulation of cell growth and apoptosis. 
According to related studies, RASSF7 protein 
has been noted in various human cell lines [28, 
32], and was found to elevate levels in the 
Figure 2. Apoptosis rate detection after up-regulated RASSF7 in IDD NP cells. A. Brightfield (left) and fluorescent 
(right) microscopy of degenerative NP cells tranfected with lentivirus labeled with green fluorescent protein. Scale 
bars =20 μm. B. Diagram of APC AnnexinV-/7-AADFCM of transfected NP cells. The graphs stand for typicalresults 
of apoptosis; values symbolize the average values of three experiments. C. Comparison of apoptotic cells between 
up-regulated RASSF7 groups and control goup (*P<0.05).
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hypoxic tissue of epithelial tumors [28, 33, 34]. 
As the intervertebral disc is the most avascular 
structure, NP tissue is in hypoxic conditions.
JNK enzymes are important modulators of 
apoptosis. JNK activation promotes the stabili-
ty and transcriptional vitality of JNK substrates, 
subsequently mediating cell apoptosis via the 
MAPKKKs-MKK4/MKK7-JNK activation path-
way. Takahashi et al. found that exclusive 
RASSF7 inhibition leads to anti-apoptotic regu-
lation and increases cell protection from inap-
propriate JNK activation [25, 35]. Recent stud-
ies delineate that JNK activation in later phase 
(1-6 h) mediates pro-apoptotic signaling [36, 
37]. NP cells play an essential role in the resis-
tance against mechanical loadings by the syn-
thesis of ECM to maintain the stability of inter-
vertebral discs. Cell loss due to apoptosis mig- 
ht lead to IDD pathological process. Based on 
the high expression level of RASSF7 in non-
degenerative NP cells, we propose that RASSF7 
modulates the apoptosis of NP cells though 
RASSF7-MKK7-JNK pathway.
We over-expressed RASSF7 in degenerative 
NP cells using lentiviral vectors. The apoptotic 
rate of degenerative NP cells with upregulated 
RASSF7 is significant lower than that in scram-
ble group. It should be stressed that the mech-
anisms of RASSF7-JNK links in human NP were 
clarified, which might cast light on the expres-
sion of RASSF7 in IDD. Previously, the function 
of RASSF7 especially in cell death has been 
noted. RASSF7 knockdown in neural tube cells 
presumably contributes to nuclear fragmenta-
tion and cell death [28, 38]. Takahashi et al. 
suggested that RASSF7 negatively regulates 
pro-apoptotic JNK signaling. In supplement 
with these studies, our findings showed that 
the apoptotic rate of degenerative NP cells was 
decreased after up-regulation of RASSF7, whi- 
ch might be due to apoptosis inhibition through 
RASSF7-JNK signaling.
Collectively, our study suggests that RASSF7 
plays an important role in human IDD and th- 
at RASSF7 could be developed as a curative 
agent.
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